Recurrent Prostate Carcinoma Clinical Trials

63 clinical trials for Recurrent Prostate Carcinoma across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer — RECRUITING
• 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer — RECRUITING · PHASE1
• REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial — RECRUITING · PHASE3
• Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial — RECRUITING · PHASE2
• Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy — COMPLETED
• Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers — ACTIVE_NOT_RECRUITING · PHASE2
• Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations — ACTIVE_NOT_RECRUITING · PHASE2
• White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA — SUSPENDED · PHASE2
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) — ACTIVE_NOT_RECRUITING · PHASE2
• Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer — COMPLETED · PHASE2
• Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation — ACTIVE_NOT_RECRUITING · PHASE1
• Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial — ACTIVE_NOT_RECRUITING · PHASE2
• Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer — COMPLETED · PHASE1
• Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer — COMPLETED · PHASE2
• A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV — ACTIVE_NOT_RECRUITING · PHASE1
• Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy — ACTIVE_NOT_RECRUITING · PHASE3
• Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide — ACTIVE_NOT_RECRUITING · PHASE2
• Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer — COMPLETED · PHASE1
• Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE4
• Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation — COMPLETED · NA
• Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction — COMPLETED · PHASE1
• Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy — COMPLETED · PHASE2
• Gallium-68 PSMA-11 PET in Participants With Prostate Cancer — WITHDRAWN · PHASE2
• Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer — COMPLETED · PHASE2
• SMMART Adaptive Clinical Treatment (ACT) Trial — WITHDRAWN · PHASE1
• Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer — OTHER · PHASE1
• Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer — COMPLETED · PHASE1
• Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer — COMPLETED · PHASE2
• Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy — TERMINATED · PHASE2
• Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer — COMPLETED
• Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7 — COMPLETED · PHASE2
• F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer — TERMINATED
• 68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment — COMPLETED · PHASE2
• Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies — TERMINATED · PHASE2
• Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T — COMPLETED · NA
• Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy — COMPLETED · PHASE3
• Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer — COMPLETED · PHASE2
• Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer — COMPLETED · PHASE2
• Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery — COMPLETED · PHASE2
• Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide — COMPLETED
• Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer — COMPLETED · PHASE1
• Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer — COMPLETED · PHASE2
• Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel — TERMINATED · PHASE2

Refine this search